UNSPSC 51285906: Hexamethylenetetramine or methenamine hippurate

This classification denotes a urinary anti-infective agent with the molecular formula C9H9NO3.C6H12N4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M329791L57, chemically known as n-benzoylglycine, compound with 1,3,5,7-tetraazatricyclo(3.3.1.13,7)decane (1:1) but more generally known as methenamine hippurate, which bears US NIH Compound Identifier 21945. European Medicines Agency schedules Methenamine hippurate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14537MIG.

SMILES: O=C(NCC(=O)O)C1CCCCC1.N12CN3CN(CN(C3)C2)C1.

UNSPSC 51285906 Hexamethylenetetramine or methenamine hippurate is a Commodity code with minimal alignment to current state and local procurement activity. The code nominally identifies a specific pharmaceutical compound used historically as a urinary antiseptic and antimicrobial agent, but recent state and local solicitations tagged with this code do not center on hexamethylenetetramine or methenamine hippurate itself. Instead, the opportunities posted under this code reflect broader healthcare procurement across pharmaceutical supply chains, emergency medical supplies, and direct-to-manufacturer pharmacy initiatives that fall outside the compound's traditional scope.

Recent solicitations show fragmented activity across health agencies and municipalities with no geographic concentration. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking naloxone and drug deactivation systems annually; the City of Tampa issued IFB 26P00145 on March 25, 2026, requesting medical and first aid supplies for the Fire Department Rescue Division with an estimated contract value of $700,000 and a small local business enterprise set-aside; the Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, to gather vendor capabilities for a direct-to-manufacturer pharmaceutical program; and the Minnesota Multistate Cooperative Purchasing Alliance issued RFP S1070000015802 on January 20, 2026, for generic multi-source pharmaceuticals and OTC products across state and local facilities in Minnesota and Oregon, with proposals due March 26, 2026. The code shows limited recent relevant activity and appears to reflect a misalignment between UNSPSC taxonomy assignment and actual procurement scope, warranting careful verification against the specific goods or services being solicited before pursuing opportunities nominally categorized under this commodity code.